Buy NGL Fine Chem; target Rs 92: Firstcall Research

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Firstcall Research's report on NGL Fine Chem

"NGL Fine-Chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health has reported its financial results for the quarter ended 31st December, 2014. The company has achieved a turnover of Rs. 192.18 million for the 3rd quarter of the current year 2014-15 as against Rs. 176.26 million in the corresponding quarter of the previous year. EBITDA of Rs. 14.52 million in Q3 FY15, a decrease of 29.21% against the corresponding period of last year. In Q3 FY15, net profit of Rs. 14.30 million against Rs. 6.31 million in the corresponding quarter of the previous year. The company has reported an EPS of Rs. 2.31 for the 3rd quarter as against an EPS of Rs. 1.02 in the corresponding quarter of the previous year."

OUTLOOK AND CONCLUSION

At the current market price of Rs. 80.00, the stock P/E ratio is at 7.64 x FY15E and 7.21 x FY16E respectively.

Earning per share (EPS) of the company for the earnings for FY15E and FY16E is seen at Rs.10.48 and Rs.11.10 respectively.

Related stories

Firstcall_Research

Firstcall Research

• 
  Buy Akzo Nobel; target of Rs 1420: Firstcall
• 
  Buy Dai-Ichi Karkar; target of Rs 430: Firstcall
• 
  Buy Lakshmi Machine; target of Rs 3600: Firstcall

Net Sales and PAT of the company are expected to grow at a CAGR of 20% and 33% over 2013 to 2016E respectively.

On the basis of EV/EBITDA, the stock trades at 5.03 x for FY15E and 4.05 x for FY16E.

Price to Book Value of the stock is expected to be at 1.59 x and 1.30 x respectively for FY15E and FY16E.

"We expect that the company surplus scenario is likely to continue for the next three years, will keep its growth story in the coming quarters also. We recommend ‘BUY’ in this particular scrip with a target price of Rs 92 for Medium to Long term investment", says Firstcall Research Report.

For all recommendations, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More